VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
DD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
DDDuPont de Nemours, Inc.
$131.60$17.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDDFinancials

DuPont de Nemours, Inc. (DD) Income Statement

30Y historyFree accessUpdated daily

Revenue contracted 44.2% YoY to $1.8B in 2026Q2, yet gross margin expanded to 35.1% from 32.3% a year earlier, indicating a richer mix and cost discipline, though operating income fell to $256M from $529M.

Income StatementBalance SheetCash FlowRatios

DD Income Statement

Annual statement

DD Income Statement

DuPont de Nemours, Inc. (DD) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue8.27B6.85B12.39B12.07B13.02B12.57B14.34B21.51B22.59B62.48B48.15B48.71B58.08B57.02B56.79B59.98B53.67B44.88B57.18B53.51B49.12B46.31B40.16B32.63B27.61B27.8B23.01B19.99B19.44B20.02B20.05B
Revenue Growth %-32.68%-44.7%2.64%-7.29%3.59%-12.36%-33.35%-4.79%-63.84%29.78%-1.15%-16.13%1.86%0.41%-5.33%11.76%19.61%-21.52%6.85%8.93%6.08%15.3%23.07%18.19%-0.7%20.85%15.1%2.81%-2.88%-0.17%-0.73%
Cost of Goods Sold5.42B4.78B8.47B8.44B8.99B8.54B9.97B15.11B16.35B49.09B37.59B38.11B47.76B47.79B48.17B51.39B46.07B39.13B51.56B46.38B41.52B38.24B34.31B28.18B23.78B23.65B17.07B14.21B13.58B13.44B12.82B
COGS % of Revenue-69.75%68.42%69.9%69.08%67.94%69.56%70.22%72.35%78.56%78.08%78.25%82.24%83.81%84.83%85.66%85.83%87.2%90.17%86.66%84.52%82.59%85.44%86.35%86.13%85.06%74.2%71.07%69.86%67.15%63.92%
Gross Profit2.84B2.07B3.91B3.63B4.03B4.03B4.36B6.41B6.25B13.39B10.56B10.6B10.32B9.23B8.62B8.6B7.61B5.74B5.62B7.14B7.6B8.06B5.85B4.46B3.83B4.15B5.94B5.78B5.86B6.58B7.24B
Gross Margin %34.39%30.25%31.58%30.1%30.92%32.06%30.44%29.78%27.65%21.44%21.93%21.75%17.76%16.19%15.17%14.34%14.17%12.8%9.83%13.34%15.48%17.41%14.56%13.65%13.87%14.94%25.8%28.93%30.14%32.85%36.08%
Gross Profit Growth %--47.03%7.68%-9.74%-0.1%-7.68%-31.88%2.53%-53.35%26.89%-0.37%2.69%11.75%7.14%0.21%13.03%32.45%2.17%-21.22%-6.15%-5.68%37.84%31.29%16.35%-7.8%-30.04%2.66%-1.31%-10.89%-9.12%-12.48%
Operating Expenses1.63B1.21B2.08B1.92B2B2.16B2.33B3.62B4.1B6.21B4.51B4.52B4.75B4.77B4.55B4.43B4.27B3.92B3.28B3.17B2.83B2.62B2.46B4.46B3.83B4.15B5.94B5.78B5.86B6.58B7.24B
OpEx % of Revenue-17.7%16.82%15.88%15.39%17.18%16.22%16.82%18.14%9.93%9.37%9.28%8.18%8.36%8.01%7.39%7.95%8.73%5.73%5.92%5.75%5.65%6.12%13.65%13.87%14.94%25.8%28.93%30.14%32.85%36.08%
Selling, General & Admin1.17B1.02B1.55B1.41B1.47B1.6B1.7B2.66B3.03B4.06B2.92B2.92B3.11B3.02B2.84B2.79B2.61B2.43B1.97B1.86B1.66B1.54B1.44B1.39B1.6B1.74B1.58B1.53B1.67B1.88B2.14B
SG&A % of Revenue-14.88%12.53%11.67%11.27%12.75%11.86%12.38%13.4%6.5%6.08%6%5.35%5.3%5%4.65%4.86%5.41%3.44%3.48%3.39%3.34%3.58%4.27%5.79%6.24%6.88%7.65%8.57%9.39%10.65%
Research & Development267M193M531M508M536M557M625M689M1.07B657M1.59B1.6B1.65B1.75B1.71B1.65B1.66B1.49B1.31B1.3B1.16B1.07B1.02B981M1.07B1.07B892M845M807M785M761M
R&D % of Revenue-2.82%4.29%4.21%4.12%4.43%4.36%3.2%4.74%1.05%3.31%3.28%2.84%3.06%3.01%2.74%3.09%3.32%2.29%2.44%2.37%2.32%2.54%3.01%3.86%3.86%3.88%4.23%4.15%3.92%3.79%
Other Operating Expenses2M00000000000000000000002.08B1.17B1.35B3.46B3.41B3.39B3.91B4.34B
Operating Income1.22B860M1.83B1.72B2.02B1.87B2.04B2.79B2.15B7.19B6.05B6.08B5.56B4.46B4.07B4.17B3.34B1.82B2.35B3.97B4.78B5.44B3.39B2.02B1.1B1.17B2.15B2.11B2.08B2.61B3.01B
Operating Margin %14.71%12.56%14.77%14.23%15.53%14.88%14.21%12.96%9.52%11.51%12.56%12.48%9.58%7.83%7.17%6.94%6.22%4.07%4.1%7.41%9.72%11.76%8.44%6.19%3.98%4.2%9.33%10.54%10.7%13.05%15.01%
Operating Income Growth %--52.98%6.52%-15.08%8.13%-8.24%-26.9%29.67%-70.09%18.89%-0.49%9.22%24.61%9.73%-2.3%24.74%82.96%-22.21%-40.86%-16.96%-12.25%60.54%67.95%83.55%-5.82%-45.6%1.95%1.2%-20.36%-13.16%-21.44%
EBITDA1.77B1.51B3.02B2.86B3.16B2.98B3.41B4.85B4.32B11.16B8.91B8.6B8.31B7.15B6.77B7.05B6.3B4.65B4.58B6.16B6.85B7.52B5.48B3.92B2.92B2.98B3.46B3.41B3.39B3.91B4.34B
EBITDA Margin %21.39%22%24.41%23.73%24.25%23.73%23.79%22.56%19.12%17.86%18.5%17.65%14.31%12.53%11.92%11.75%11.74%10.37%8.01%11.51%13.95%16.25%13.64%12.02%10.59%10.73%15.05%17.04%17.42%19.53%21.63%
EBITDA Growth %-43.91%-50.15%5.55%-9.28%5.87%-12.58%-29.73%12.36%-61.28%25.24%3.62%3.45%16.3%5.6%-3.99%11.86%35.45%1.53%-25.58%-10.13%-8.93%37.31%39.7%34.09%-1.94%-13.84%1.61%0.62%-13.4%-9.87%-17.72%
D&A (Non-Cash Add-back)552M647M1.19B1.15B1.14B1.11B1.37B2.07B2.17B3.97B2.86B2.52B2.75B2.68B2.7B2.88B2.96B2.83B2.24B2.19B2.07B2.08B2.09B1.9B1.82B1.81B1.31B1.3B1.3B1.3B1.33B
EBIT777M513M1.56B900M1.94B1.97B-1.57B194M655M2.28B5.27B10.88B6.25B7.91B2.93B4.94B4.27B2.04B1.92B4.82B5.6B7.12B4.54B2.02B1.1B1.17B2.15B2.11B2.08B2.61B3.01B
Net Interest Income-184M-215M-293M-241M-442M-513M-660M-613M-16M6M-751M-875M-932M-1.06B-1.23B-1.3B-1.44B-1.53B-561M-464M-447M-584M-661M00000000
Interest Income57M98M73M155M50M12M12M55M39M6M107M71M51M41M41M40M37M39M86M130M185M138M86M00000000
Interest Expense241M313M366M396M492M525M672M667M55M0858M946M983M1.1B1.27B1.34B1.47B1.57B648M584M632M722M747M00000000
Other Income/Expense-508M-660M-637M-1.21B-574M-426M-4.28B-3.26B-1.55B-6B-1.63B3.85B-299M2.34B-2.4B-564M-537M-1.36B-1.07B262M195M955M405M-268M-1.72B-1.78B189M-9M-86M236M85M
Pretax Income708M200M1.19B504M1.45B1.44B-2.25B-474M600M1.19B4.41B9.93B5.26B6.8B1.67B3.6B2.8B469M1.28B4.23B4.97B6.4B3.8B1.75B-622M-613M2.34B2.1B2B2.85B3.09B
Pretax Margin %8.57%2.92%9.62%4.18%11.12%11.49%-15.66%-2.2%2.66%1.91%9.17%20.39%9.07%11.93%2.93%6%5.22%1.05%2.23%7.9%10.12%13.82%9.45%5.37%-2.25%-2.2%10.15%10.49%10.26%14.23%15.43%
Income Tax167M102M414M-29M387M237M160M140M195M-476M9M2.15B1.43B1.99B565M817M481M-97M651M1.24B1.16B1.78B877M-82M-280M-228M823M766M685M1.04B1.19B
Effective Tax Rate %23.59%51%34.73%-5.75%26.73%16.41%-7.12%-29.54%32.5%-39.9%0.2%21.62%27.08%29.22%33.93%22.69%17.17%-20.68%50.98%29.42%23.23%27.85%23.1%-4.68%45.02%37.19%35.23%36.53%34.34%36.54%38.36%
Net Income55M-779M703M423M5.87B6.47B-2.95B497M3.83B1.45B4.3B7.63B3.75B4.75B1.17B2.71B2.31B648M579M2.89B3.72B4.54B2.8B1.73B-338M-385M1.51B1.33B1.31B1.81B1.91B
Net Margin %0.67%-11.37%5.68%3.51%45.08%51.46%-20.58%2.31%16.94%2.32%8.92%15.67%6.45%8.33%2.06%4.52%4.3%1.44%1.01%5.39%7.58%9.79%6.96%5.3%-1.22%-1.38%6.58%6.66%6.74%9.03%9.51%
Net Income Growth %128.5%-210.81%66.19%-92.79%-9.26%319.15%-693.76%-87.02%164.55%-66.32%-43.73%103.85%-21.14%306.24%-56.9%17.4%256.48%11.92%-79.94%-22.48%-17.88%62.14%61.68%611.83%12.21%-125.45%13.67%1.6%-27.54%-5.19%-7.92%
Net Income (Continuing)541M98M778M533M1.06B1.21B-2.41B-614M405M1.67B4.4B7.78B3.84B4.82B1.1B2.78B2.32B566M626M2.98B3.82B4.62B2.92B1.74B-405M-417M1.51B1.33B1.31B1.81B1.91B
Discontinued Operations-2M-836M-40M-71M4.86B5.31B-517M1.14B3.48B-77M0000000110M28M000000000000
Minority Interest112M184M443M446M448M617M566M569M1.61B1.6B1.24B809M931M1.03B990M1.01B803M569M69M414M365M336M449M376M366M357M410M408M532M676M2.09B
EPS (Diluted)0.40-5.585.042.8234.8335.64-12.032.0114.858.1931.6855.3525.8333.126.3018.4515.482.885.5826.9134.3841.5826.3716.83-3.33-3.8719.985.915.7623.107.59
EPS Growth %131.91%-210.71%78.72%-91.9%-2.27%396.26%-698.51%-86.46%81.32%-74.15%-42.76%114.29%-22.01%425.71%-65.85%19.19%437.5%-48.39%-79.26%-21.73%-17.32%57.68%56.68%605.41%13.95%-119.37%238.07%2.6%-75.06%204.35%-67.23%
EPS (Basic)--5.615.042.8234.8935.76-12.032.0114.948.2832.1358.0526.1933.486.3918.5415.752.885.5827.2734.8342.2126.8216.92-3.33-3.8720.166.005.8223.437.71
Diluted Shares Outstanding137.2M139.73M140.2M150.4M166.47M181.4M245.17M248.77M257.28M177.57M124.8M137.93M131.89M143.38M130.71M128.69M127.09M117.1M104.33M107.29M108.27M108.53M105.98M102.9M101.17M100.2M99.77M73.6M73.46M78.27M80.38M
Basic Shares Outstanding136.3M139.17M139.73M149.97M166.17M180.9M245.17M248.77M255.67M175.53M123.12M125.57M130.1M131.8M129.97M127.67M125.1M115.91M103.38M105.9M106.92M107.02M104.46M102.09M101.17M100.2M99.77M73.6M73.46M76.87M80.38M
Dividend Payout Ratio--90.33%153.9%11.11%9.74%-324.14%91.2%234.55%57.31%29.51%53.94%31.14%175.36%46.39%43.9%158.95%269.95%52.37%37.7%28.38%44.76%71.04%--51.75%57.93%60%41.92%39.28%

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

PFAS litigation overhang

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Divestiture-Driven Revenue Contraction

Revenue fell 44.2% YoY in 2026Q2 to $1.8B, reflecting the Mobility & Materials divestiture, but sequential stability suggests the remaining portfolio is finding a floor. According to the latest income statement data, the decline is perimeter-driven, not organic.

The steep year-over-year declines in 2026Q1 and Q2 (-45.2% and -44.2%) align with the completion of the Mobility & Materials sale, leaving a smaller, more focused revenue base. Sequential revenue has been essentially flat around $1.7-1.8B over the last two quarters, which may indicate that the divestiture impact is largely behind the company. Investors should monitor whether organic growth can resume in the Electronics & Industrial and Water & Protection segments, as the current trajectory is purely a function of portfolio reshaping.

Gross Margin Resilience Amid Shrinkage

Gross margin expanded to 35.1% in 2026Q2, up from 32.3% a year earlier, suggesting a richer mix post-divestiture. As reported in the financial statements, this improvement appears driven by a higher proportion of specialty products.

Despite the dramatic revenue decline, gross margins have improved by roughly 300 basis points year-over-year, indicating that the remaining businesses carry higher pricing power. This is consistent with the company's shift toward semiconductor materials and water technologies, which typically command premium margins. However, the sustainability of this margin level depends on maintaining utilization rates in a high-fixed-cost manufacturing environment, especially if electronics demand softens.

Operating Leverage Masked by Cost Cuts

Operating margin rose to 14.1% in 2026Q2 from 14.9% in 2025Q2, but with revenue down 44%, the absolute operating income fell from $529M to $256M. Based on the income statement data, cost discipline appears to be offsetting volume losses.

The company has aggressively reduced SG&A and R&D expenses in absolute terms, with SG&A down from $405M to $269M year-over-year, a 34% cut. This suggests management is prioritizing cost efficiency to protect profitability during the transition. However, the lack of revenue growth means operating leverage is negative; any future volume recovery could drive outsized earnings growth given the leaner cost base.

Earnings Distorted by One-Time Items

Net income swung from a $589M loss in 2025Q1 to a $143M profit in 2026Q2, but the path includes large impairments and restructuring charges. According to the reported figures, EPS of $1.05 in 2026Q2 is not indicative of sustainable earnings power.

The negative net margins in 2025Q4 and 2025Q3, along with the massive loss in 2025Q1, are likely tied to divestiture-related charges and asset write-downs. The recent profitability may reflect a cleaner cost structure, but investors should adjust for one-time items to assess core earnings. The absence of stock-based compensation in earlier quarters and its modest presence in 2026 suggests limited dilution, but the quality of earnings remains clouded by non-operating noise.

Cost Rationalization Drives Margin Recovery

SG&A as a percentage of revenue fell to 14.8% in 2026Q2 from 12.3% in 2025Q2, while R&D dropped from $142M to $42M. As per the income statement data, this aggressive cost cutting is the primary driver of margin recovery.

The dramatic reduction in R&D spending, from over $140M per quarter to $42M, raises questions about the company's ability to sustain its 'qualified-in' status in semiconductor materials. While cost cuts boost short-term margins, they may undermine long-term innovation and competitive positioning. Investors should monitor whether R&D intensity stabilizes at a level sufficient to support next-generation product development.

Sustainability of Earnings Beat Questioned

The Q2 2026 EPS beat of $1.88 versus $1.45 estimate may be flattered by cost cuts and one-time gains, not organic growth. Given the 44% revenue decline, the earnings quality warrants skepticism.

Short-sellers might argue that the earnings beat is a result of aggressive cost reduction and favorable one-time items, masking the underlying revenue weakness. The negative revenue growth for five consecutive quarters suggests that the core business is not expanding, and the reliance on cost discipline is not a durable growth strategy. Additionally, unresolved PFAS liabilities could lead to future charges that erode the apparent profitability.

DD — Frequently Asked Questions

Quick answers to the most common questions about buying DD stock.

What was DuPont de Nemours, Inc.'s (DD) revenue in 2025?

For fiscal year 2025, DuPont de Nemours, Inc. (DD) reported total revenue of $6.85B. This represents a 65.8% decline compared to $20.05B in 1996.

Is DuPont de Nemours, Inc. (DD) profitable?

DuPont de Nemours, Inc. (DD) reported a net loss of $779.0M for the fiscal year ending 2025.

What is DuPont de Nemours, Inc.'s operating profit margin?

DuPont de Nemours, Inc. (DD) reported an operating income of $860.0M, resulting in an operating profit margin of 12.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is DuPont de Nemours, Inc.'s gross profit and gross margin?

DuPont de Nemours, Inc. (DD) generated $2.07B in gross profit for the year, representing a gross profit margin of 30.3%. This demonstrates the company's core pricing power and production efficiency.